M&A in Healthcare: 2024 Outlook
Alpha Sense BI
MARCH 13, 2024
This emerging trend is allowing pharmaceutical companies—large and small—to distinguish themselves among competitors and investors as they pioneer advancements fueled by AI. The ability to bring drugs and therapies to market sooner, with less intrinsic cost, ultimately leads to stronger valuations and greater stakeholder value.
Let's personalize your content